Deltex Medical Group Plc engages in manufacturing and sale of advanced haemodynamic monitoring technologies. It operates through the following four segments: Probes, Monitors, Third Party Products and Other. Its products include ODM+, Dopplers Probes, HD Impedeance Cardiography, Cerebral Oximetry and Laryngoscopes. The company was founded on January 6, 2000 and is headquartered in Chichester, the United Kingdom.